The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
The Mavericks' mid-season rash of injuries continued on Saturday with the loss of backup big man Maxi Kleber. The Associated Press Maxi Kleber joins Dereck Lively and Dwight Powell among the Mavs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback